Developments in biological and informational technology are significantly advancing our understanding of health and disease and of how to preserve, improve and restore wellbeing. Implementing new technologies poses challenges that may require us to rethink or redesign standards, practices, roles and institutions.
We aim to support the responsible innovation of emerging health technologies, focusing on understanding disease, risk prediction and diagnostics, as well as advanced, genome-based therapies. This will require informed analysis and evaluation of both the technologies and the context of implementation, taking into account ethical, social and legal aspects. It will require new approaches to innovation governance that are anticipatory, flexible and responsive.
